Adcock Ingram is a South African pharmacutical company. The company is dived into two divisions, its pharmastical business and its health care business with a market capitalisation of about R

South African rand

The rand is the currency of South Africa. It takes its name from the Witwatersrand , the ridge upon which Johannesburg is built and where most of South Africa's gold deposits were found. The rand has the symbol "R" and is subdivided into 100 cents, symbol "c"...

9 billion.

Adcock Ingram was bought out by Tiger Brands

Tiger Brands

Tiger Brands Limited is a South African packaged goods company. In addition to the company's South African operations Tiger Brands also has direct and indirect interests in international food businesses in Chile, Zimbabwe, Kenya and Cameroon...

 in 1999 but was unbundled from Tiger Brands and re-listed on the Johannesburg Stock Exchange after alleged anti-competitive practices in April 2008. Tiger was fined R53.5 million after an investigation concluded that "the allegations of collusive tendering and market allocation made in the complaint referral against AICC were, on a balance of probabilities, substantially correct."

The company currently has a 10% share of the private pharmaceutical industry in South Africa.

History

Adcock Ingram first started out as a pharmacy in Krugersdorp trading under the name EJ Adcock Pharmacy 120 years ago. In the early 1900s, Hyme Tannenbaum was apprenticed to then owner, Jack Blair. Hyme's brothers Jack, Len and Archie soon followed him into the pharmacy, which they eventually bought. Beginning with this one small pharmacy, the Tannenbaum brothers built a cross-country chain of retail pharmacies, a pharmaceutical and toiletry manufacturing giant and a highly respected South African success story. Adcock was first listed on the Johannesburg Stock Exchange in 1950. The company was sold to Tiger Brands in 1999 for R3.4 billion. In August 2008 Adcock relisted on the JSE with 172.6 million ordinary issued shares at a price of R33.50 each.

Pharmaceutical brands

Adcock Ingram made R1,054 million from its pharmaceutical division in 2010.

Health care brands